Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension.

Nature genetics | 2013

At least 5% of individuals with hypertension have adrenal aldosterone-producing adenomas (APAs). Gain-of-function mutations in KCNJ5 and apparent loss-of-function mutations in ATP1A1 and ATP2A3 were reported to occur in APAs. We find that KCNJ5 mutations are common in APAs resembling cortisol-secreting cells of the adrenal zona fasciculata but are absent in a subset of APAs resembling the aldosterone-secreting cells of the adrenal zona glomerulosa. We performed exome sequencing of ten zona glomerulosa-like APAs and identified nine with somatic mutations in either ATP1A1, encoding the Na(+)/K(+) ATPase α1 subunit, or CACNA1D, encoding Cav1.3. The ATP1A1 mutations all caused inward leak currents under physiological conditions, and the CACNA1D mutations induced a shift of voltage-dependent gating to more negative voltages, suppressed inactivation or increased currents. Many APAs with these mutations were <1 cm in diameter and had been overlooked on conventional adrenal imaging. Recognition of the distinct genotype and phenotype for this subset of APAs could facilitate diagnosis.

Pubmed ID: 23913004 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

None found

Antibodies used in this publication

Associated grants

  • Agency: Medical Research Council, United Kingdom
    Id: G0600717
  • Agency: British Heart Foundation, United Kingdom
    Id: FS/11/35/28871
  • Agency: Wellcome Trust, United Kingdom
    Id: 098360/Z/12/Z
  • Agency: Wellcome Trust, United Kingdom
    Id: 085686/Z/08/A
  • Agency: Medical Research Council, United Kingdom
    Id: MR/K501050/1
  • Agency: Wellcome Trust, United Kingdom
    Id: 098360
  • Agency: Austrian Science Fund FWF, Austria
    Id: F 4402
  • Agency: Wellcome Trust, United Kingdom
    Id: 098497
  • Agency: Austrian Science Fund FWF, Austria
    Id: W 1101
  • Agency: British Heart Foundation, United Kingdom
    Id: PG/07/085/23349

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Anti-Cav1.3 Ca2+ Channel Antibody (antibody)

RRID:AB_10673964

This monoclonal targets Cav1.3 Ca2+ channel

View all literature mentions